ResearcherUniversity of ThessalyNo recent work listed
Konstantinos S. Dimas
Matched on ORCID iD 0000-0001-7481-9148; OpenAlex author ID A5022844446. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper
Papers 9
- Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine? Last author DOI 10.3390/biomedicines11030890↗
- Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.21873/invivo.12809↗
- Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. Last author DOI 10.3390/medicina58111663↗
- In Silico Transcriptomic Analysis of the Chloride Intracellular Channels (CLIC) Interactome Identifies a Molecular Panel of Seven Prognostic Markers in Patient… Co-author DOI 10.2174/1389202921666200316115631↗
- Transcriptomic analysis of the Aquaporin (AQP) gene family interactome identifies a molecular panel of four prognostic markers in patients with pancreatic duct… Co-author DOI 10.1016/j.pan.2019.02.006↗
- Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic ca… Last author DOI 10.3892/ijo.2018.4640↗
- Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devastating cancer? Last author DOI 10.1016/j.jprot.2018.01.012↗
- Self-Healing pH- and Enzyme Stimuli-Responsive Hydrogels for Targeted Delivery of Gemcitabine To Treat Pancreatic Cancer. Co-author DOI 10.1021/acs.biomac.8b00959↗
- Polymersomes from polypeptide containing triblock Co- and terpolymers for drug delivery against pancreatic cancer: asymmetry of the external hydrophilic blocks. First author DOI 10.1002/mabi.201400137↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dimitrios E. Magouliotis · 5 shared papers, 2018–2022 · strength 0.64
- Paper Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma. DOI 10.21873/invivo.12809↗
- Paper Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. DOI 10.3390/medicina58111663↗
- Paper In Silico Transcriptomic Analysis of the Chloride Intracellular Channels (CLIC) Interactome Identifies a Molecular Pane… DOI 10.2174/1389202921666200316115631↗
- Evangelia Sereti · 3 shared papers, 2018–2023 · strength 0.47
- Paper Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine? DOI 10.3390/biomedicines11030890↗
- Paper Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devas… DOI 10.1016/j.jprot.2018.01.012↗
- Paper Self-Healing pH- and Enzyme Stimuli-Responsive Hydrogels for Targeted Delivery of Gemcitabine To Treat Pancreatic Cance… DOI 10.1021/acs.biomac.8b00959↗
- Dimitris Zacharoulis · 3 shared papers, 2019–2022 · strength 0.43
- Paper Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma. DOI 10.21873/invivo.12809↗
- Paper Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. DOI 10.3390/medicina58111663↗
- Paper Transcriptomic analysis of the Aquaporin (AQP) gene family interactome identifies a molecular panel of four prognostic … DOI 10.1016/j.pan.2019.02.006↗
- Dimitris Zacharoulis · 2 shared papers, 2018–2020 · strength 0.21
- Paper In Silico Transcriptomic Analysis of the Chloride Intracellular Channels (CLIC) Interactome Identifies a Molecular Pane… DOI 10.2174/1389202921666200316115631↗
- Paper Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devas… DOI 10.1016/j.jprot.2018.01.012↗
- Konstantinos Vellios Kamposioras · 2 shared papers, 2018–2019 · strength 0.17
- Paper Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and … DOI 10.3892/ijo.2018.4640↗
- Paper Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devas… DOI 10.1016/j.jprot.2018.01.012↗
- Anna P. Karamolegkou · 1 shared paper, 2022 · strength 0.15
- Hermis Iatrou · 2 shared papers, 2014–2018 · strength 0.13
- Paper Self-Healing pH- and Enzyme Stimuli-Responsive Hydrogels for Targeted Delivery of Gemcitabine To Treat Pancreatic Cance… DOI 10.1021/acs.biomac.8b00959↗
- Paper Polymersomes from polypeptide containing triblock Co- and terpolymers for drug delivery against pancreatic cancer: asym… DOI 10.1002/mabi.201400137↗
- Alan Anthoney · 1 shared paper, 2019 · strength 0.08
- Caroline Sophie Verbeke · 1 shared paper, 2019 · strength 0.08
- Engı̇n Ulukaya · 1 shared paper, 2018 · strength 0.08
- Panayiotis Bilalis · 1 shared paper, 2018 · strength 0.08
- Sosanna Sofianopoulou · 1 shared paper, 2014 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.